Your browser doesn't support javascript.
COVID-19 was not associated or trigger disease activity in spondylarthritis patients: ReumaCoV-Brasil cross-sectional data.
Marques, Claudia Diniz Lopes; Ribeiro, Sandra Lúcia Euzébio; Albuquerque, Cleandro P; de Sousa Studart, Samia Araujo; Ranzolin, Aline; de Andrade, Nicole Pamplona Bueno; Dantas, Andrea T; Mota, Guilherme D; Resende, Gustavo G; Marinho, Adriana O; Angelieri, Danielle; Andrade, Danieli; Ribeiro, Francinne M; Omura, Felipe; Silva, Nilzio A; Rocha Junior, Laurindo; Brito, Danielle E; Fernandino, Diana C; Yazbek, Michel A; Souza, Mariana P G; Ximenes, Antonio Carlos; Martins, Ana Silvia S; Castro, Glaucio Ricardo W; Oliveira, Lívia C; Freitas, Ana Beatriz S B; Kakehasi, Adriana M; Gomides, Ana Paula M; Reis Neto, Edgard Torres; Pileggi, Gecilmara S; Ferreira, Gilda A; Mota, Licia Maria H; Xavier, Ricardo M; de Medeiros Pinheiro, Marcelo.
  • Marques CDL; Hospital das Clínicas - Universidade Federal de Pernambuco, Recife, Brazil.
  • Ribeiro SLE; Universidade Federal do Amazonas, Manaus, Brazil.
  • Albuquerque CP; Universidade de Brasília (HUB-UnB-EBSERH), Brasília, Brazil.
  • de Sousa Studart SA; Hospital Geral de Fortaleza (HGF), Fortaleza, Brazil.
  • Ranzolin A; Hospital Getúlio Vargas, Recife, Brazil.
  • de Andrade NPB; Hospital de Clínicas de Porto Alegre - Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
  • Dantas AT; Hospital das Clínicas - Universidade Federal de Pernambuco, Recife, Brazil.
  • Mota GD; Universidade Federal de São Paulo, Rua Borges Lagoa, 913/ 51-53, Vila Clementino, São Paulo, SP, CEP: 04038-034, Brazil.
  • Resende GG; Hospital das Clínicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
  • Marinho AO; Fundação Hospitalar do Acre (Fundhacre), Rio Branco, Brazil.
  • Angelieri D; Hospital dos Servidores de São Paulo - IAMSPE, São Paulo, Brazil.
  • Andrade D; Hospital das Clínicas, Universidade de São Paulo, São Paulo, Brazil.
  • Ribeiro FM; Hospital Universitário Pedro Ernesto, Universidade do Estado do Rio de Janeiro, Abraão, Brazil.
  • Omura F; Clínica Omura Medicina Diagnóstica, São Paulo, Brazil.
  • Silva NA; Faculdade de Medicina da Universidade Federal de Goiás, Goiânia, Brazil.
  • Rocha Junior L; Instituto de Medicina Integral Professor Fernando Figueira -IMIP, Recife, Brazil.
  • Brito DE; Universidade Federal da Paraíba, João Pessoa, Brazil.
  • Fernandino DC; Universidade Federal de Juiz de Fora, Juiz de Fora, Brazil.
  • Yazbek MA; Hospital de Clínicas da Universidade Estadual de Campinas- UNICAMP, Campinas, Brazil.
  • Souza MPG; Santa Casa de Belo Horizonte, Belo Horizonte, Brazil.
  • Ximenes AC; CIP - Centro Internacional de Pesquisa, Goiânia, Brazil.
  • Martins ASS; Hospital de Clínicas, Universidade Federal de Uberlândia, Uberlândia, Brazil.
  • Castro GRW; Hospital Governador Celso Ramos - Santa Catarina, Florianópolis, Brazil.
  • Oliveira LC; Hospital Santa Casa de Misericórdia de Vitória, Vitória, Brazil.
  • Freitas ABSB; Faculdade de Ciências da Saúde Paulo Prata- FACISB, Barretos, Brazil.
  • Kakehasi AM; Hospital das Clínicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
  • Gomides APM; UniCEUB, Brasília, DF, Brazil.
  • Reis Neto ET; Universidade Federal de São Paulo, Rua Borges Lagoa, 913/ 51-53, Vila Clementino, São Paulo, SP, CEP: 04038-034, Brazil.
  • Pileggi GS; Universidade Federal de São Paulo, Rua Borges Lagoa, 913/ 51-53, Vila Clementino, São Paulo, SP, CEP: 04038-034, Brazil.
  • Ferreira GA; Hospital das Clínicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
  • Mota LMH; Programa de Pós-Graduação em Ciências Médicas, Faculdade de Medicina, Universidade de Brasília (PPGCM-FM-UnB), Brazil, Brasília, DF, Brazil.
  • Xavier RM; Hospital Universitário de Brasília (HUB-UnB-EBSERH), Brasília, DF, Brazil.
  • de Medeiros Pinheiro M; Hospital de Clínicas de Porto Alegre - Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Adv Rheumatol ; 62(1): 45, 2022 Nov 22.
Article in English | MEDLINE | ID: covidwho-2139794
ABSTRACT

OBJECTIVES:

To evaluate the disease activity before and after COVID-19 and risk factors associated with outcomes, including hospitalization, intensive care unit (ICU) admission, mechanical ventilation (MV) and death in patients with spondylarthritis (SpA).

METHODS:

ReumaCoV Brazil is a multicenter prospective cohort of immune-mediated rheumatic diseases (IMRD) patients with COVID-19 (case group), compared to a control group of IMRD patients without COVID-19. SpA patients enrolled were grouped as axial SpA (axSpA), psoriatic arthritis (PsA) and enteropathic arthritis, according to usual classification criteria.

RESULTS:

353 SpA patients were included, of whom 229 (64.9%) were axSpA, 118 (33.4%) PsA and 6 enteropathic arthritis (1.7%). No significant difference was observed in disease activity before the study inclusion comparing cases and controls, as well no worsening of disease activity after COVID-19. The risk factors associated with hospitalization were age over 60 years (OR = 3.71; 95% CI 1.62-8.47, p = 0.001); one or more comorbidities (OR = 2.28; 95% CI 1.02-5.08, p = 0.001) and leflunomide treatment (OR = 4.46; 95% CI 1.33-24.9, p = 0.008). Not having comorbidities (OR = 0.11; 95% CI 0.02-0.50, p = 0.001) played a protective role for hospitalization. In multivariate analysis, leflunomide treatment (OR = 8.69; CI = 95% 1.41-53.64; p = 0.023) was associated with hospitalization; teleconsultation (OR = 0.14; CI = 95% 0.03-0.71; p = 0.01) and no comorbidities (OR = 0.14; CI = 95% 0.02-0.76; p = 0.02) remained at final model as protective factor.

CONCLUSIONS:

Our results showed no association between pre-COVID disease activity or that SARS-CoV-2 infection could trigger disease activity in patients with SpA. Teleconsultation and no comorbidities were associated with a lower hospitalization risk. Leflunomide remained significantly associated with higher risk of hospitalization after multiple adjustments.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Arthritis, Psoriatic / Spondylarthritis / COVID-19 Type of study: Cohort study / Etiology study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Humans / Middle aged Country/Region as subject: South America / Brazil Language: English Journal: Adv Rheumatol Year: 2022 Document Type: Article Affiliation country: S42358-022-00268-x

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Arthritis, Psoriatic / Spondylarthritis / COVID-19 Type of study: Cohort study / Etiology study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Humans / Middle aged Country/Region as subject: South America / Brazil Language: English Journal: Adv Rheumatol Year: 2022 Document Type: Article Affiliation country: S42358-022-00268-x